Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Küpfer

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Developmental Medicine and Child Neurology|February 1, 1981
Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing complianceT Zysset, A Rüdeberg, F Vassella, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agentsP Dayer, L Balant, A Küpfer, et al.
Biochemical Pharmacology|March 1, 1986
Defective bile acid transport in an animal model of defective debrisoquine hydroxylationJ Reichen, S Krähenbühl, A Küpfer, et al.
Schweizerische Medizinische Wochenschrift|July 24, 1982
[Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]B Dick, A Küpfer, J Molnàr, et al.
Clinical Science and Molecular Medicine|February 1, 1978
Hepatic metabolism of aminopyrine in patients with chronic renal failureS Scherrer, B Haldimann, A Küpfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1981
Induction of drug-metabolizing enzymes by the enantiomers of normephenytoin in the ratR James, A Küpfer, J P Villeneuve, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humansS Fritz, W Lindner, I Roots, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylationP Dayer, T Leemann, A Küpfer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzeneR James, P Desmond, A Küpfer, et al.
British Journal of Clinical Pharmacology|April 1, 1988
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquineM Eichelbaum, L Bertilsson, A Küpfer, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Developmental Medicine and Child Neurology|February 1, 1981
Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing complianceT Zysset, A Rüdeberg, F Vassella, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agentsP Dayer, L Balant, A Küpfer, et al.
Biochemical Pharmacology|March 1, 1986
Defective bile acid transport in an animal model of defective debrisoquine hydroxylationJ Reichen, S Krähenbühl, A Küpfer, et al.
Schweizerische Medizinische Wochenschrift|July 24, 1982
[Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]B Dick, A Küpfer, J Molnàr, et al.
Clinical Science and Molecular Medicine|February 1, 1978
Hepatic metabolism of aminopyrine in patients with chronic renal failureS Scherrer, B Haldimann, A Küpfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1981
Induction of drug-metabolizing enzymes by the enantiomers of normephenytoin in the ratR James, A Küpfer, J P Villeneuve, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humansS Fritz, W Lindner, I Roots, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylationP Dayer, T Leemann, A Küpfer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzeneR James, P Desmond, A Küpfer, et al.
British Journal of Clinical Pharmacology|April 1, 1988
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquineM Eichelbaum, L Bertilsson, A Küpfer, et al.
Pageof 6